VOLU SOL INC
10QSB, EX-27, 2000-08-21
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: VOLU SOL INC, 10QSB, 2000-08-21
Next: KEMPER GLOBAL INTERNATIONAL SERIES, 24F-2NT, 2000-08-21



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>               SEP-30-2000
<PERIOD-START>                  APR-01-2000
<PERIOD-END>                    JUN-30-2000
<CASH>                                         516,243
<SECURITIES>                                         0
<RECEIVABLES>                                   95,371
<ALLOWANCES>                                    (2,188)
<INVENTORY>                                     50,772
<CURRENT-ASSETS>                               862,386
<PP&E>                                         399,650
<DEPRECIATION>                                (345,125)
<TOTAL-ASSETS>                                 920,608
<CURRENT-LIABILITIES>                          359,941
<BONDS>                                              0
                                0
                                  3,626,111
<COMMON>                                           287
<OTHER-SE>                                  (3,065,731)
<TOTAL-LIABILITY-AND-EQUITY>                   920,608
<SALES>                                        119,724
<TOTAL-REVENUES>                               119,724
<CGS>                                           44,944
<TOTAL-COSTS>                                   44,944
<OTHER-EXPENSES>                             1,519,174
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (1,510,287)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (1,510,287)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,510,287)
<EPS-BASIC>                                      (1.00)
<EPS-DILUTED>                                    (1.00)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission